BI 695500
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BI 695500, covering 2017-01-30 to 2018-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma [Phase 1]